Griebel G

References (5)

Title : Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents - Griebel_2015_Sci.Rep_5_7642
Author(s) : Griebel G , Pichat P , Beeske S , Leroy T , Redon N , Jacquet A , Francon D , Bert L , Even L , Lopez-Grancha M , Tolstykh T , Sun F , Yu Q , Brittain S , Arlt H , He T , Zhang B , Wiederschain D , Bertrand T , Houtmann J , Rak A , Vallee F , Michot N , Auge F , Menet V , Bergis OE , George P , Avenet P , Mikol V , Didier M , Escoubet J
Ref : Sci Rep , 5 :7642 , 2015
PubMedID: 25560837
Gene_locus related to this paper: mouse-ABHD6

Title : SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile - Biton_2007_Neuropsychopharmacology_32_1
Author(s) : Biton B , Bergis OE , Galli F , Nedelec A , Lochead AW , Jegham S , Godet D , Lanneau C , Santamaria R , Chesney F , Leonardon J , Granger P , Debono MW , Bohme GA , Sgard F , Besnard F , Graham D , Coste A , Oblin A , Curet O , Vige X , Voltz C , Rouquier L , Souilhac J , Santucci V , Gueudet C , Francon D , Steinberg R , Griebel G , Oury-Donat F , George P , Avenet P , Scatton B
Ref : Neuropsychopharmacology , 32 :1 , 2007
PubMedID: 17019409

Title : SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia - Pichat_2007_Neuropsychopharmacology_32_17
Author(s) : Pichat P , Bergis OE , Terranova JP , Urani A , Duarte C , Santucci V , Gueudet C , Voltz C , Steinberg R , Stemmelin J , Oury-Donat F , Avenet P , Griebel G , Scatton B
Ref : Neuropsychopharmacology , 32 :17 , 2007
PubMedID: 16936709

Title : Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic - Depoortere_2005_Neuropsychopharmacology_30_1963
Author(s) : Depoortere R , Dargazanli G , Estenne-Bouhtou G , Coste A , Lanneau C , Desvignes C , Poncelet M , Heaulme M , Santucci V , Decobert M , Cudennec A , Voltz C , Boulay D , Terranova JP , Stemmelin J , Roger P , Marabout B , Sevrin M , Vige X , Biton B , Steinberg R , Francon D , Alonso R , Avenet P , Oury-Donat F , Perrault G , Griebel G , George P , Soubrie P , Scatton B
Ref : Neuropsychopharmacology , 30 :1963 , 2005
PubMedID: 15956994

Title : 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylp henyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization - Gully_2002_J.Pharmacol.Exp.Ther_301_322
Author(s) : Gully D , Geslin M , Serva L , Fontaine E , Roger P , Lair C , Darre V , Marcy C , Rouby PE , Simiand J , Guitard J , Gout G , Steinberg R , Rodier D , Griebel G , Soubrie P , Pascal M , Pruss R , Scatton B , Maffrand JP , Le Fur G
Ref : Journal of Pharmacology & Experimental Therapeutics , 301 :322 , 2002
PubMedID: 11907190